Skip to Main content Skip to Navigation
Conference papers

Usefulness of Tc-99m Sestamibi studies for monitoring response to therapy in patients with high grade gliomas: a preliminary study

Abstract : Early and late Sestamibi studies were acquired in addition to conventional MRI protocol in 14 patients with high-grade gliomas to monitor an antiangiogenic treatment. Global and local indices were deduced from these SPECT studies and were compared with progression free survival (PFS) and overall survival (OS). Variations of intensity in late studies were not correlated with PFS, but were related to OS. This suggests the possible role of Sestamibi for monitoring response to treatment.
Document type :
Conference papers
Complete list of metadata

Cited literature [2 references]  Display  Hide  Download

https://www.hal.inserm.fr/inserm-01143772
Contributor : Nathalie Duchange Connect in order to contact the contributor
Submitted on : Monday, April 20, 2015 - 11:03:40 AM
Last modification on : Friday, December 3, 2021 - 12:12:55 PM
Long-term archiving on: : Wednesday, April 19, 2017 - 12:13:15 AM

File

ACTES-RITS2015-HALp48-49.pdf
Files produced by the author(s)

Licence


Distributed under a Creative Commons Attribution 4.0 International License

Identifiers

  • HAL Id : inserm-01143772, version 1

Citation

Jean-Marc Tacchella, Nathanaelle Yeni, Gregorio Petrirena, Mike-Ely Cohen, Muriel Lefort, et al.. Usefulness of Tc-99m Sestamibi studies for monitoring response to therapy in patients with high grade gliomas: a preliminary study. Journées RITS 2015, Mar 2015, Dourdan, France. pp.48-49. ⟨inserm-01143772⟩

Share

Metrics

Record views

443

Files downloads

472